Literature DB >> 14654892

How to assess prognostic models for survival data: a case study in oncology.

M Schumacher1, E Graf, T Gerds.   

Abstract

OBJECTIVES: A lack of generally applicable tools for the assessment of predictions for survival data has to be recognized. Prediction error curves based on the Brier score that have been suggested as a sensible approach are illustrated by means of a case study.
METHODS: The concept of predictions made in terms of conditional survival probabilities given the patient's covariates is introduced. Such predictions are derived from various statistical models for survival data including artificial neural networks. The idea of how the prediction error of a prognostic classification scheme can be followed over time is illustrated with the data of two studies on the prognosis of node positive breast cancer patients, one of them serving as an independent test data set. RESULTS AND
CONCLUSIONS: The Brier score as a function of time is shown to be a valuable tool for assessing the predictive performance of prognostic classification schemes for survival data incorporating censored observations. Comparison with the prediction based on the pooled Kaplan Meier estimator yields a benchmark value for any classification scheme incorporating patient's covariate measurements. The problem of an overoptimistic assessment of prediction error caused by data-driven modelling as it is, for example, done with artificial neural nets can be circumvented by an assessment in an independent test data set.

Entities:  

Mesh:

Year:  2003        PMID: 14654892

Source DB:  PubMed          Journal:  Methods Inf Med        ISSN: 0026-1270            Impact factor:   2.176


  9 in total

1.  Circulating microRNAs as biomarkers of radiation-induced cardiac toxicity in non-small-cell lung cancer.

Authors:  Peter G Hawkins; Yilun Sun; Robert T Dess; William C Jackson; Grace Sun; Nan Bi; Muneesh Tewari; James A Hayman; Gregory P Kalemkerian; Shirish M Gadgeel; Theodore S Lawrence; Randall K Ten Haken; Martha M Matuszak; Feng-Ming Spring Kong; Matthew J Schipper; Shruti Jolly
Journal:  J Cancer Res Clin Oncol       Date:  2019-03-28       Impact factor: 4.553

2.  Assessing the performance of prediction models: a framework for traditional and novel measures.

Authors:  Ewout W Steyerberg; Andrew J Vickers; Nancy R Cook; Thomas Gerds; Mithat Gonen; Nancy Obuchowski; Michael J Pencina; Michael W Kattan
Journal:  Epidemiology       Date:  2010-01       Impact factor: 4.822

3.  Considerations for the prediction of survival time in pancreatic cancer based on registry data.

Authors:  Gaurav Bajaj; Erin Dombrowsky; Qilu Yu; Banke Agarwal; Jeffrey S Barrett
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-07-12       Impact factor: 2.745

4.  Learning rule sets from survival data.

Authors:  Łukasz Wróbel; Adam Gudyś; Marek Sikora
Journal:  BMC Bioinformatics       Date:  2017-05-30       Impact factor: 3.169

5.  Validation of discrete time-to-event prediction models in the presence of competing risks.

Authors:  Rachel Heyard; Jean-François Timsit; Leonhard Held
Journal:  Biom J       Date:  2019-07-31       Impact factor: 2.207

6.  Prospective target assessment and multimodal prediction of survival for personalized and risk-adapted treatment strategies in multiple myeloma in the GMMG-MM5 multicenter trial.

Authors:  Dirk Hose; Susanne Beck; Hans Salwender; Martina Emde; Uta Bertsch; Christina Kunz; Christoph Scheid; Mathias Hänel; Katja Weisel; Thomas Hielscher; Marc S Raab; Hartmut Goldschmidt; Anna Jauch; Jérôme Moreaux; Anja Seckinger
Journal:  J Hematol Oncol       Date:  2019-06-26       Impact factor: 17.388

7.  Clinical characteristics and disease-specific prognostic nomogram for primary gliosarcoma: a SEER population-based analysis.

Authors:  Song-Shan Feng; Huang-Bao Li; Fan Fan; Jing Li; Hui Cao; Zhi-Wei Xia; Kui Yang; Xiao-San Zhu; Ting-Ting Cheng; Quan Cheng
Journal:  Sci Rep       Date:  2019-07-24       Impact factor: 4.379

8.  A web-based tool for personalized prediction of long-term disease course in patients with multiple sclerosis.

Authors:  I Galea; C Lederer; A Neuhaus; P A Muraro; A Scalfari; N Koch-Henriksen; C Heesen; S Koepke; P Stellmann; H Albrecht; A Winkelmann; F Weber; E Bahn; M Hauser; G Edan; G Ebers; M Daumer
Journal:  Eur J Neurol       Date:  2012-12-07       Impact factor: 6.089

9.  Prognostic Evidence of the miRNA-Based Ovarian Cancer Signature MiROvaR in Independent Datasets.

Authors:  Loris De Cecco; Marina Bagnoli; Paolo Chiodini; Sandro Pignata; Delia Mezzanzanica
Journal:  Cancers (Basel)       Date:  2021-03-27       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.